Literature DB >> 32665670

Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation.

Zihan Zhou1,2, Xianguo Zhou1, Yanji Jiang1,2, Moqin Qiu1,2, Xiumei Liang1, Qiuling Lin1,2, Qian Guo3, Cunli Nong3, Rongrui Huo1, Qian Chen1, Haizhou Liu1, Yingchun Liu1, Shaoliang Zhu4, Mengyun Wang5, Hongping Yu6.   

Abstract

miRNAs play an indispensable role in human carcinogenesis. Dysregulated miR-1180-3p has been observed in several types of cancer, including hepatocellular carcinoma (HCC). This study intends to correlate the expression level of miR-1180-3p with clinical features and overall survival in HCC patients. The expression and clinical significance of miR-1180-3p, selected from GEO and TCGA databases, were verified using an RT-qPCR method. The target genes of miR-1180-3p were obtained using 3 miRNA target gene prediction databases, and their functions were analyzed using the online tool WebGestalt. miR-1180-3p expression was significantly upregulated in 88 HCC tissues compared with non-tumor liver tissues (0.004 ± 0.009 vs. 0.002 ± 0.002, t = - 2.099, P = 0.038). Additionally, we found that the expression levels of miR-1180-3p were significantly correlated with tumor number (χ2 = 9.157, P = 0.006) and MVI (χ2 = 11.354, P = 0.003). Based on Kaplan-Meier analysis, patients with high miR-1180 expression had a shorter overall survival than those with low miR-1180-3p expression (P = 0.002). Furthermore, multivariate Cox analyses indicated that miR-1180-3p expression was an independent prognostic factor for overall survival (HR = 13.36, 95% CI 1.16, 153.69, P = 0.038). In addition, a total of 733 target genes of miR-1180-3p were found from three prediction databases. The GO analyses demonstrated that the target genes were closely related to the proliferation and malignancy of tumors. The KEGG analysis showed that target genes were enriched in several key cancer-related signaling pathways, including the Pathways in cancer, the Ras signaling pathway, and the MAPK signaling pathway. In conclusion, we demonstrate that miR-1180-3p is upregulated in HCC and is associated with a poor prognosis. Thus, miR-1180-3p might be useful as a prognostic marker for HCC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32665670      PMCID: PMC7360737          DOI: 10.1038/s41598-020-68450-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  30 in total

1.  Body Fatness and Cancer--Viewpoint of the IARC Working Group.

Authors:  Béatrice Lauby-Secretan; Chiara Scoccianti; Dana Loomis; Yann Grosse; Franca Bianchini; Kurt Straif
Journal:  N Engl J Med       Date:  2016-08-25       Impact factor: 91.245

2.  Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Authors:  Claudia Allemani; Tomohiro Matsuda; Veronica Di Carlo; Rhea Harewood; Melissa Matz; Maja Nikšić; Audrey Bonaventure; Mikhail Valkov; Christopher J Johnson; Jacques Estève; Olufemi J Ogunbiyi; Gulnar Azevedo E Silva; Wan-Qing Chen; Sultan Eser; Gerda Engholm; Charles A Stiller; Alain Monnereau; Ryan R Woods; Otto Visser; Gek Hsiang Lim; Joanne Aitken; Hannah K Weir; Michel P Coleman
Journal:  Lancet       Date:  2018-01-31       Impact factor: 79.321

Review 3.  Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.

Authors:  Shu-Chun Chuang; Carlo La Vecchia; Paolo Boffetta
Journal:  Cancer Lett       Date:  2008-12-16       Impact factor: 8.679

Review 4.  MicroRNA and cancer.

Authors:  Martin D Jansson; Anders H Lund
Journal:  Mol Oncol       Date:  2012-10-09       Impact factor: 6.603

Review 5.  The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome.

Authors:  Alyson P Black; Anand S Mehta
Journal:  Curr Opin Pharmacol       Date:  2018-05-14       Impact factor: 5.547

6.  MicroRNAs associated with metastatic prostate cancer.

Authors:  Akira Watahiki; Yuwei Wang; James Morris; Kristopher Dennis; Helena M O'Dwyer; Martin Gleave; Peter W Gout; Yuzhuo Wang
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

7.  Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma.

Authors:  Jia Ji; Yuan Rong; Chang-Liang Luo; Shuo Li; Xiang Jiang; Hong Weng; Hao Chen; Wu-Wen Zhang; Wen Xie; Fu-Bing Wang
Journal:  Front Oncol       Date:  2018-12-03       Impact factor: 6.244

8.  Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.

Authors:  Zhenhai Li; Kwan Yeung Wong; George A Calin; Wee-Joo Chng; Godfrey Chi-Fung Chan; Chor Sang Chim
Journal:  Clin Epigenetics       Date:  2019-05-07       Impact factor: 6.551

9.  A cis-eQTL genetic variant in PLK4 confers high risk of hepatocellular carcinoma.

Authors:  Lijuan Meng; Yan Zhou; Sihan Ju; Jing Han; Ci Song; Jing Kong; Yifei Wu; Shuai Lu; Jiani Xu; Wenwen Yuan; Erbao Zhang; Cheng Wang; Zhibin Hu; Yayun Gu; Rongcheng Luo; Xuehao Wang
Journal:  Cancer Med       Date:  2019-09-06       Impact factor: 4.452

Review 10.  A comprehensive evaluation for polymorphisms in let-7 family in cancer risk and prognosis: a system review and meta-analysis.

Authors:  Ben-Gang Wang; Li-Yue Jiang; Qian Xu
Journal:  Biosci Rep       Date:  2018-07-31       Impact factor: 3.840

View more
  3 in total

Review 1.  The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma.

Authors:  Suliman Khan; De-Yu Zhang; Ji-Yu Zhang; Mian Khizar Hayat; Jingli Ren; Safyan Nasir; Muhammad Fawad; Qian Bai
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

2.  Molecular and genetic markers in hepatocellular carcinoma: In silico analysis to clinical validation (current limitations and future promises).

Authors:  Sarah El-Nakeep
Journal:  World J Gastrointest Pathophysiol       Date:  2022-01-22

3.  Clinical significance of microRNA-1180-3p for colorectal cancer and effect of its alteration on cell function.

Authors:  Chunlei Li; Wei Jin; Dewei Zhang; Shoujin Tian
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.